Seoul, South Korea

Jione Pyeon


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jione Pyeon in Antibiotic Development

Introduction

Jione Pyeon, an inventive mind based in Seoul, South Korea, has made significant strides in the field of antibiotic research. With a singular patent to his name, Pyeon is dedicated to addressing critical health challenges posed by gram-negative bacteria.

Latest Patents

Jione Pyeon's recent patent, titled "Polypeptide, fusion polypeptide, and antibiotic against gram-negative bacteria comprising same," represents a milestone in antibiotic innovation. The patent describes a novel polypeptide derived from a bacteriophage, along with a fusion polypeptide comprising cecropin A. This invention has important implications for the medical field, offering a promising solution to combat infections caused by gram-negative bacteria.

Career Highlights

Pyeon is currently affiliated with Lysentech Co., Ltd., where his research and development efforts contribute to the advancement of biomedical technologies. His work emphasizes the creation of effective therapeutic agents and showcases his commitment to improving public health through innovation.

Collaborations

Throughout his career, Jione Pyeon has collaborated with notable colleagues including Heejoon Myung and Min Soo Kim. These partnerships have fostered a stimulating environment for research and development, leading to groundbreaking advancements in their respective fields.

Conclusion

In conclusion, Jione Pyeon stands out as an innovative inventor in the realm of antibiotics. With his patent addressing gram-negative bacterial infections, Pyeon is poised to make a substantial impact on healthcare solutions. His affiliations and collaborations further enhance his contributions, making him a notable figure in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…